Bailard, Inc. Procept Bio Robotics Corp Transaction History
Bailard, Inc.
- $3.84 Billion
- Q4 2024
A detailed history of Bailard, Inc. transactions in Procept Bio Robotics Corp stock. As of the latest transaction made, Bailard, Inc. holds 11,386 shares of PRCT stock, worth $751,476. This represents 0.02% of its overall portfolio holdings.
Number of Shares
11,386
Previous 13,386
14.94%
Holding current value
$751,476
Previous $1.07 Million
14.55%
% of portfolio
0.02%
Previous 0.03%
Shares
4 transactions
Others Institutions Holding PRCT
# of Institutions
284Shares Held
40MCall Options Held
262KPut Options Held
257K-
Vanguard Group Inc Valley Forge, PA5.14MShares$339 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.49MShares$230 Million0.0% of portfolio
-
Alliancebernstein L.P. New York, NY1.75MShares$116 Million0.05% of portfolio
-
Wellington Management Group LLP Boston, MA1.49MShares$98.4 Million0.02% of portfolio
-
Loomis Sayles & CO L P1.21MShares$79.7 Million0.12% of portfolio
About PROCEPT BioRobotics Corp
- Ticker PRCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 44,592,300
- Market Cap $2.94B
- Description
- PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aqu...